ROIV
🟢 Roivant Sciences is trading 4.9% up today after Q4 earnings beat and $770M Moderna settlement gain
Roivant Sciences is trading at $36.20 (+4.91%) in pre-market action after fiscal Q4 2026 results significantly beat analyst expectations due to a major...